What is the Share Price of Brooks Laboratories Ltd?

Brooks Laboratories Ltd share price is ₹111.40 As on 31 October, 2025|12:00

Home
>
Stocks
>
Brooks Laboratories Ltd

Brooks Laboratories Ltd Share Price

Q: What is the Market Cap of Brooks Laboratories Ltd?

The Market Cap of Brooks Laboratories Ltd is ₹329 As on 31 October, 2025|12:00

Q: What is PE Ratio of Brooks Laboratories Ltd?

The P/E ratio of Brooks Laboratories Ltd is 55.5 As on 31 October, 2025|12:00

Q: What is PB Ratio of Brooks Laboratories Ltd?

The PB ratio of Brooks Laboratories Ltd is 2.79 As on 31 October, 2025|12:00

₹ 111.40 -0.22 (-0.20%)
Updated on 31-10-2025 12:00 PM

Stock Rating

Pros 3

Cons 6

Brooks Laboratories Ltd Price Performance

Day's Low
₹111.1

Day's High
₹116

₹ 111.4

52-w low
₹95.55

52-w high
₹198.86

111.4

Day's open
₹112.8
Previous close
₹111.620003
VWAP
₹112.93
Lower price band
₹100.45
Upper price band
₹122.78

Today's Market Action

The last traded share price of Brooks Laboratories Ltd was 111.40 down by -0.20% on the NSE. Its last traded stock price on BSE was 111.30 up by 0.13%. The total volume of shares on NSE and BSE combined was 27,740 shares. Its total combined turnover was Rs 0.31 crores.

Brooks Laboratories Ltd Medium and Long Term Market Action

Brooks Laboratories Ltd hit a 52-week high of 198.86 on 07-01-2025 and a 52-week low of 95.55 on 28-02-2025. The stock price of Brooks Laboratories Ltd is down by -15% over the last one month. It is down by -16.03% over the last one year. Don't forget to check the full stock price history in the table below.

Brooks Laboratories Ltd Fundamentals

Market Cap (Cr): 329
Book Value (₹):
Stock P/E:
Revenue (Cr):
Total Debt (Cr):

Face Value (₹):
Roce (%):
ROE (%):
Earnings (Cr):
Promoter’s Holdings (%):

EPS (₹):
Debt to Equity:
Dividend Yield (%):
Cash (Cr):

Brooks Laboratories Ltd Mutual fund holdings and trends

FUND NAME	Quantity	Monthly Change (Qty)

Brooks Laboratories Ltd Shareholding Pattern

Similar Stocks

Company	Price	Market Cap (Cr)	P/E

About Brooks Laboratories Ltd

Data not available.

Brooks Laboratories Ltd FAQ's

What is Share Price of Brooks Laboratories Ltd?

What is the Market Cap of Brooks Laboratories Ltd?

What is PE Ratio of Brooks Laboratories Ltd?

What is PB Ratio of Brooks Laboratories Ltd?

What is the CAGR of Brooks Laboratories Ltd?

How to Buy Brooks Laboratories Ltd Share?

Can I buy Brooks Laboratories Ltd from Samco?

How do I buy Brooks Laboratories Ltd from Samco?

Financials

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Net Profit)

Standalone Financial Performace In Graph(Net Profit)

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Net Profit)

Standalone Financial Performace In Graph(Net Profit)

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Cash Flow)

Standalone Financial Performace In Graph(Cash Flow)

News

Review

Pros

Asset Light Business
The company operates a great asset light business with a high Asset turnover ratio of 5.32. A high asset turnover ratio is a great driver of RoE and can improve shareholder returns. A relatively higher asset turnover ratio also will result in lower dilution as the business grows its revenues as earnings.
Zero Debt
The company has almost nil to negligible debt to equity ratio of 0.07. Considering the fact that the business is debt free, equity shareholders shall carry lower risk of holding the stock.
Strong Working Capital Cycle
The company has a great working capital cycle of 0 days which results in lower investments in working capital and higher asset turnover. This reduces capital requirement of the business and drives RoE and cash flow generation positively. This is extremely positive for long term shareholders of the business.

Cons

Low Sustainable RoE
The company's sustainable return on equity is lower than the expected cost of capital which implies that the underlying business will destruct value over a period of time due to it's inability to generate superior returns on capital.
Low Return on Capital Employed
The company is unable to generate sufficient return on capital employed which impairs it's ability to generate high return for shareholders after accounting for taxes, interest and other non-equity stakeholders.
Poor Cash Flow Conversion
The business has very poor cash conversion ratio of only -232.13% of operating earnings getting converted into operating cash flow. This implies that increase in profits has not translated into higher cash flows for the business and incrementally higher investments in working capital which works negatively for shareholders.
Low Interest Coverage
The company has a very low Interest coverage ratio of 3.82 times which implies that a large portion of operating profits are getting attributed to payment of interest to debtholders. This leaves lower earnings and cash flows for equity shareholders which is negative for returns.
Highly Cyclical Industry
The company operates an extremely cyclical business with unpredictable earnings and cash flows. This shall result in very high stock price volatility and returns which would negatively impact shareholder returns.
Low Pricing Power & High Competition
The business has extremely low pricing power and is vulnerable to competitive pressure which can significantly impact shareholder returns.

Valuation Analysis

Margin of safety
(31/10/2025)

106

Margin of Safety Index: Very High

100.00%

100.00% People are bullish about Brooks Laboratories Ltd

0.00%

0.00 % People are bearish about Brooks Laboratories Ltd

What is your opinion about this Stock?

Historical Data

Date	Open	High	Low	Close	Volume	Daily Change %